We have located links that may give you full text access.
The juvenile court and delinquency cases.
Future of Children 1996
Growing public concern about the rise in violent juvenile crime is borne out by increases in the juvenile court's caseload, which rose 23% between 1989 and 1993. The number of cases involving person offenses increased by 52%. Despite the rise in person offenses, the majority of delinquency cases in juvenile court involve property offenses, and less than 10% of the caseload consists of violent offenses. Almost all juveniles commit at least one delinquent act before turning 18, but most are never arrested. This article follows those youths who are arrested on the pathway through the juvenile justice system. Of all delinquency cases referred to juvenile court, approximately one quarter are dismissed or diverted for handling outside the court process. Another quarter of the cases are handled through informal court processes, while the remaining 51% of cases are formally processed through the juvenile court. At all stages of the juvenile court process, there is an overrepresentation of black youths in relation to their representation in the population at large. In 1993, while only 15% of the juvenile population was black, black youths were involved in 28% of all arrests and 50% of all violent crime arrests. A meta-analysis of the literature on minority youths in the juvenile court found that racial and ethnic status influenced the decisions made about individual youths at every stage of the juvenile court process. Juvenile offenders with four or more arrests are responsible for nearly two-thirds of all violent crimes and half of all property crimes referred to court. The author concludes that early intervention into the lives of these youths is necessary to address the increase in juvenile crime.
Full text links
Trending Papers
A Personalized Approach to the Management of Congestion in Acute Heart Failure.Heart International 2023
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium-Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure.International Journal of Molecular Sciences 2024 Februrary 21
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app